Rating History for Xylem (XYL) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/21/2026 | Mark Strouse | Downgrade | Neutral (Overweight) |
130.00 (N/A) |
120.62 (122.59) |
1.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/21/2026 | Mark Strouse | Downgrade | Neutral (Overweight) |
130.00 (N/A) |
120.62 (122.59) |
1.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||